Serial laboratory determinations are now routinely performed on patients admitted tointensive-care units. Adequateinterpretation of such cumulative information for clinical decisionmaking purposes is a challenging problem. We describe a statistical method for predicting-sequentially as the data become available-the patient's outcome,deathorsurvival. Thus the method goes beyond previously reported techniques that base such prediction on only a single multivariate observation. The methodhas been applied todaily measurementsofserum ureaand lactate dehydrogenase, performed duringone week on patients hospitalized inthecoronarycare unitwith acute myocardial infarction. Two baseline variables were also included in the dynamic risk index so derived: the age of the patient and the number of previous myocardial infarctions recorded on admission. We also discuss the problems of selecting the most-predictive laboratory tests and of determining for each test the amount of past data needed to achieve satisfactory prediction. We distinguish between global evaluation of the dynamic risk index obtained (in terms of specificityand sensitivity) and individual interpretation (in terms of posterior/prior probability ratio) of a given risk score for a particular patient. These considerations led one of us to develop a theory of discriminant analysis (7) based on multivariate response curves, which was successfully applied to a retrospective data base of more than 300 patients with MI (6). Although exhibiting interesting dynamic characteristics, the method was essentially descriptive and did not account for the actual time of death of nonsurvivors, a drawback that we have already mentioned for the classical approach. This prompted us to propose a new methodology for upgrading the interpretation of serial laboratory measurements recorded from patients admitted to coronary-care units.
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The Data Base
Our study material consisted of 330 patients with documented MI admitted to the two coronary-care units of the
University
Hospital, Liege, Belgium. Acute MI was diagnosed on the basis of typical clinical history, electrocardiographic evidence, and a rise and fall of CK and LD activities in serum.
Age (in years) and the number of previous MIs were recorded for each patient at admission. The mean age of the 
10591).
The clinical significance and the evolutionary characteristics of these laboratory tests after an acute MI have been extensively studied and reported in a series of papers (14-16). For illustrative purposes, we have restricted our attention here to the statistical treatment of three constituents only: AGP, a "positive" acute-phase reactant possibly related to the healing of the jeopardized myocardium (17) ; urea, which is likely to reflect proteolysis and possible hemodynamic impairment consequent to MI (18); and LD, the amount of which is known to be closely related to the size of the infarct (14). Because uric acid, creatinine, and urea, as well as CK and LD are highly correlated, we expected that little would be gained by adding the remaining variables.
Finally, the patient's status, "alive" or "deceased," was recorded every day for all patients in the data base.
The Statistical Problem
We are faced with the situation where patients are being measured at equally spaced time points t (e.g., every day) up Let Yt denote the outcome variable in the tth interval of time, and assume that Yt takes only two values, namely, 1 for "alive" and 2 for "dead." It follows that for each patient in the data base, we can define a "sequence of states" (y1, Y2,
of maximum length T. In our application, T = 7 and every sequence is a series of l's terminated by either 1 or 2 depending on whether the patient survived or died. For example, a patient dying in the fourth time interval [3, 4] has the sequence (1,1,1,2), because he was alive during the first three days after admission and died on the fourth. Likewise, a patient alive at the end of the one-week investigation period yields a full sequence of l's. Let Xt denote the vector of all observations made on the patient up to and including time t. This vector may consist of (a) baseline or "constant" variables measured only once, for example, age and previous MIs on admission, and (b) serial measurements of AGP, urea, and LD. The question that we propose to answer-namely, how to assess on a daily basis the patient's survival chances from previously recorded measurements-reduces to the following statistical problem: "predict at each time-point t the outcome variable Yt from the information vectorXt available up to time t; or in other words, compute the probability
The problem is akin to classical regression analysis, where one proposes to predict the patient's outcome from a vector of observations. In the present situation, however, both the outcome and the predictor variables are time dependent. Additionally, there is a double selection problem, namely, (a) to determine the best combination of predictive variables, and (b) to decide upon thenumber of past observations that are needed to achieve a satisfactory prediction at each time point. For instance, only the current or last two measurements of the selected variables might suffice for assessing the patient's risk, earlier observations having no effect on the outcome at time t.
Clearly, the number of possible "variable/time-point" combinations to be tested in the regression analysis increases dramatically with the number of components of vector Xt. Thus, in practice, one usually proceeds hierarchically with models of increasing complexity and stops the process when no statistically significant improvementcan be obtained in the prediction of outcome.
In sum, one must keep in mind the quest for the most parsimonious model and select the minimum number of past observations needed.
The Prediction Model
In the following, we shall assume that the vector 7(2 has the same length p at each time t, and denote its elements as x1 xi,, remembering that the values of these elements generally change with time t.
The basic model for prediction of a dichotomous response variable based on repeated measurements was recently proposed by Wu and Ware (19), and applied to three yearly measurements made in two cohorts obtained in the Framingham Heart Study. This model, namely,
assumes that the probability of death in the interval better to reality. The drawback, however, is that the weights have to be estimated for each variable at each time point-a difficult task. One possible solution would be to apply at each time t-i.e., every day-a classical discriminant analysis between survivors and "next-day" nonsurvivors. This approach is usually not feasible, because the number of deaths each day is small as compared withthe number of patients still alive. Alternatively, onecan subtract from the observations some deterministic part of the response to the disease process, so as to bring stability to the time series observed. In this case, a model with constant coefficients can be postulated for the transformed variables, greatly simplifying the computations.
The two-stage approach. Fig. I survivors.
Because the response curves envisaged in our study were obtained by simple linear interpolation between successive measurements, the correction above merely consisted in standardizing every observation at time t, i.e., by subtracting the mean and dividing by the standard deviation for the one-year survivor group at that time. We emphasize that this transformation was applied only to time-dependent variables, not to baseline variables such as age or previous MIs.
Let Z' = (z1, ..., z,) denote the vector of transformed elements of X'. It is clear that, on average, the elements of Z' fluctuate around 0 for low-risk patients (one-year survivors)
andaround some positive value for high-risk patients (early deaths). Therefore the assumption of constant coefficients in the logistic model 1 becomes realistic.
In sum, we propose a two-stage approach for solving the problem of dynamic outcome prediction in acute myocardial infarction.
The method consists of (a) transforming the original time-dependent variables as described above, and (b) assuming for the transformed set of data the logistic model
where b0 and b' = (b1, ..., br,) are now a set of unknown "constant" parameters to be estimated from the data base. We shall call the linear function S(t) = b0 + b'Z' the "risk index" at time t. As in classical discriminant analysis, this index can take any value on the real line, increased values being associated with high risk of death, easily seen from equation 2; conversely, large negative scores are signs of good prognosis.
Estimation.
Model 2 can be postulated for any combination of vector Zt, dependingon how many elements are included in this vector. For each model M considered, the problem then reduces to estimating the coefficients of the risk function S(t), by using the information contained in the data base. The number of parameters to be estimated for each model is obviously equal to p + 1, i.e., the p weights associated with each element of vector Z' and the intercept b0.
Estimation of the parameters was obtained by maximiz- 
1-3).
8Nonsignificant at the 5% level by an asymptotically normal significance test. ing the logarithm of the likelihood function of the sample, noted by log L.
To find out which model best fits the observations, we used a log-likelihood ratio criterion asymptotically distributed as a chi-square test. We also computed Akaike's Information Criterion (24), which is particularly appropriate when attempting to select a good model from among many alternatives.
This criterion combines for each model the maximized likelihood (logL) with the number of parameters estimated (p + 1). By definition, AIC = -2 log L + 2(p + 1), and the procedure chooses as the "best" model the one for which AIC is a minimum.
Results
For each patient in the data base, we associated a sequence of states as described above under The Statistical
Probkm.
We tallied the number of nonsurvivors in each time interval, and included in the last interval all patients who died between days 7 and 15, patients with such early death also being considered as high-risk patients ( Table 1 ). The total number who died during the monitoring period was 33 (10%).
As described above, the time-dependent variables AGP, urea, and U) were standardized-i.e., Z = (x -)/SD-to eliminate the deterministic component of the disease response and to apply the simplified model 2. Table 2 gives the means and standard deviations of the response curves for the one-year survivors at each day for these three laboratory tests. We note from Table 2 and from Figures 1-3 that (a) there is a steady increase of AGP and urea from admission until theend of the first week, and (b) LD activities reach a maximum on the second day after admission, then regularly decrease until the last day. 
Fitting of Models
Several models were fitted to the data (Table 3 ). For each model M, we determined (a) the maximum of the log- 
Model Ml: Prior probabilities.
The simplest model is to assume that there are no covariates in the risk index, i.e., no baseline variables and no time-dependent variables; thus S(t) = b0. This model is equivalent to assuming that, on the average, the prior probabilities of survival (P1) and death (P2) are constant in every time interval. The ML estimate of b0 was found to be -4.18. Consequently, by equation 2, the daily probability of death is P2 = 0.0 15 and the probability of survival P1 = 0.985. Allocation of the individual patients into survivor and nonsurvivor groups is not possible merely on the basis of overall prior probabilities. Therefore, it is anticipated that adding the baseline variables (age and previous MIs) and serial laboratory measurements into the risk function will improve predictions.
Model M2: Effect of age. The introduction of age significantly improved model Ml: x2= 2(log L2 -log L1) = 15.58, S(t) = -7.14 + 0.038 age + 0.58PT + 0.38 u1 + 0.31 l (3)
Akaike's criterion decreased by 13.6 units.
The risk function obtained was S(t) = -8.87 + 0.077 age.
Hence, a 70-year-old patient has, on the average, a daily probability of death of P2 = 0.033 [S(t) = -3.39], twice as much as we found above.
Model M3: Effect of previous
MIs. The addition of the number of previous MIs to age produced no significant difference at the 5% critical level ( = 3.46, not significant), although the ratio of b2 to its standard error (0.51/0.24= 2.13) exceeded 1.96, the upper 2.5% point of the gaussian distribution.
We decided, however, to keep previous MIs in the riskindex, because in previous studies (6, 22) this parameter was always significantly efficient in discriminating survivors and nonsurvivors.
Models M4-M6:
Use of the current biochemical observation. In these models, we added to age and previous MIs only the most recent observation of AGP (M4), urea (M5), or LD (M6). By comparing each of these models with model M3, we found LI) to be the best biochemical parameter to use in improving outcome prediction (x2 = 37.28 vs 3.48 for AGP and 36.66 for urea), and concluded that AGP did not help much in assessing the current patient's condition. This result seems to contradict the high F-value (7.05) we found when comparing the three risk categories depicted in Figure  1 . The two situations, however, are entirely different. In one case, we looked at early deaths only, and in the other at patients dying later, after hospital discharge. Actually, we showed that the effect of AGP only appears later in the course of the disease (15) and that AGP probably is the best biochemical test for making a long-term prognosis (26). Note that blood urea was nearly as good a predictor as LD. When we say this, what we mean is that the current (or most recent) value of U) or urea at time t is a good predictor of outcome in the next time interval.
At this point, we know that prediction is not significantly improved by AGP, but is improved by the knowledge of urea and U). Now two further questions need to be answered: (a) Do past values of LD or urea improve the predictive power of the current observation? (b) If we combine urea and LD, do we obtain a better risk index than using each test separately? Models M7, 8: Effect of previous laboratory measurements.
As the results clearly indicate, prediction was not significantly improved by adding to the current value (time t) the previous
one (time t-l).
For urea, the log-likelihood increased from -143.70 to -143.05, leading to a x2valueof 1.30 (not significant). Likewise for U), we found a nonsignificant value of x2= 0.54. Hence, only the most recent observation is needed to obtain satisfactory dynamic outcome prediction in patients suffering from MI. In fact, high correlations were found between successive standardized test results across the population.
Model M9: Joint effect of urea and LD. When we combined both urea and LD (most recent results) with age and previous MIs in the risk index, there was a considerable benefit in prediction efficiency. When we compared models M3 and M9, thelog-likelihood ratio test obtained was highly significant: x2 = 58.64 on two degrees of freedom. Model M9 was also the one for which the value for Akaike's Information Criterion reached a minimum, 275.44. Adding to M9 either AGP or previous observations of urea and LD yielded only redundant and unnecessary information.
The Dynamic PrognosticIndexand ItsEfficiency
From the fitting of the various models, we concluded that thebest risk index, that providing optimal dynamic outcome prediction, was given by the following equation (bias correction applied to the coefficients):
where P1 is the number of previous MIs, and u1 and i represent the current observations of urea and U), standardized as described above (by using Table 2 group D), we determined the highest value of S(t), i.e., the poorest score during the oneweek study period, whereas for the 33 patients who died (nonsurvivors: group D), we recorded the score just preceding death. We studied the distributions of these scores for both groups by applying a likelihood ratio approach as described elsewhere (27) . By using the cutoff point where the two distributions intersect (S* = -3.88), we correctly allocated 238 survivors (specificity = 80%) and 24 nonsurvivors (sensitivity = 73%) to their groups, thus yielding a total efficiency of nearly 80%. For comparative purposes, when the risk index was based on age and previous MIs alone (thus excluding the serial values of urea and LD), specificity and sensitivity dropped respectively to 67% and 58% (total efficiency, 66%).
There is another way to appraise the predictive power of the risk index obtained. For each patient in the data base, we computed the accumulated probability of death conditional on the observations available from admission until the end of the seven-day period (or until death for nonsurvivors). If P(t) denotes the conditional probability of death in the tth interval of time as given by equation 2, then the accumulated probability of death associated with every patient, noted ir, is computed from the relations IT = P(1) + t2 P(t)fl [1 - where 'r equals the actual time of death for nonsurvivors and (r = 7) for survivors. As shown in Figure 4 , the cumulative frequency distributions of these probabilities ir in survivors (n = 297) and in nonsurvivors (n = 33) are notably distinct. For instance, an accumulated probability of death of at least 0.15 was obtained in only 10% of survivors, but in more than 40% of nonsurvivors, emphasizing the difference between the two groups. Practically, one can say that any value of ir exceeding 10% was a clear sign of poor prognosis.
The excellent performance of this dynamic risk index derived from our data base was recently confirmed on a test sample of 76 more MI patients. From among the 11 patients who died during hospital stay, eight (73%) had a scorelarger than the critical cutoff point of -3.88 before death. Among the 65 survivors, 54 (83%) showed persistent negative values less than -3.88 during the one-week monitoring period.
Interpretation of Individual Risk Scores
The data above provide an overall evaluation of the 'If we regard the accumulated probability v as a function ofT (= 2, 3, . . .), not as an end-study statistic, it could be computed sequentially (i.e., every day) as a warning sign that increased therapeutic effort is necessary. The complementary function a(r) = 1 -ift) actually represents the probability of survival conditional on past observations collected from the patient. of the dynamic prognostic index based on age, previous MIs, urea, and U). We may, however, investigate the implication of a given index score on the predicted outcome of an individual patient. As an illustration (Table   4) , we computed the daily risk scores S(t) and the corresponding probabilities P(t), using equations 2 and 3, for two patients selected from the data base. and he died on the third day. Before death(t = 2), he had a score of S(2) = -1.36 and his probability ofdeath for the next day was 21%. Comparing this result with the unconditional probability of death found previously (see model Ml: P2 = 0.015) shows more than a 10-fold increase.
Patient 2, 75 years old, died one month after hospitalization; he had had no previous infarct. His highest index score during the first week of hospital stay was recorded on day 4, S(4) = -2.30. This value, well above the critical score of -3,88, indicates that the patient had an index value that is found more frequently in nonsurvivors than in survivors. Likewise his probability of death at that time was 0.091, sixfold greater than the prior probability of 0.015. These results confirm that the patient was already at high risk during his hospital stay, and they may have provided a hint of the late fatal outcome. 
33) groups
The practical use of the methodology proposed is straight- and serial data of every patient in the data base. We assume that measurements are made at regular time intervals-for instance, every day-and that there is a logistic relation between survival probability and risk index. It is known, however, that logistic models are robust and applicable to a mixture of discrete and continuous variables (20, 21, 27) . Moreover, as shown in our application, baseline variables (e.g., age, previous MIs) and time-dependent variables (e.g., urea, LD) can be handled with equal facility. We have also emphasized that maximum likelthood estimation of the coefficients of the linear risk index is simplified when these coefficients do not depend on time (stationary model). To achieve this property in our series of observations, we adjusted the individual response curves by subtracting the deterministic component of the evolution. We decided to consider the one-year survivors (patients at lowest risk in our data base) as providing the typical evolutionary pattern of LD and urea after MI. The choice of the deterministic component should not affect the general results of our study, for we are interested in outcome prediction in the early phase of the disease. It is merely a convenient way of stabilizing the observation series and allowing the use of a simple logistic regression model.
Test selection considerations in dynamic prognosis have been alluded to and are twofold. First, which biochemical test should be included in the dynamic index, and what combination of tests provides the best prediction? Second, how many past observations should be used for each variable? In our application, we studied three constituents but only urea and LD were useful discriminators; AGP did not contribute significantly to outcome prediction. Furthermore, the most recent observations of urea and LD were sufficient for assessing satisfactorily the patient's status.
Our results confirm the importance of LD in short-term prognosis of acute MI and its relationship to infarct size (14). They also re-emphasize the preponderant role of serum urea in monitoring patients with acute diseases (18). As for age and number of previous episodesof MI, several studies have confirmed their prognostic effectiveness in acute MI (6,22).
In conclusion, the linear risk index derived from our data base enables one to predict, on a daily basis, the patient's survival chances from simple demographic data and from urea and LD measurements, as they become available. We believe that the methodology developed should enhance the interpretation of cumulative laboratory results, not only in acute MI, but also in any disease in which there is an acute phase during which the patient is closely monitored and multiple serial measurements are made.
